A Guide to Improving Field Force Performance with Marketing Mix Modeling
Field force remains one of the most critical communication channels for pharmaceutical companies. We emphasize the word “communication” rather than just “marketing” channel, because field force represents far more than promotion—it is the primary way to convey the value of your product, build trust with healthcare professionals, and highlight your competitive advantages to potential customers.
With the support of Marketing Mix Modeling (MMM), pharmaceutical companies can not only measure the true contribution of their field force but also identify strategies to enhance its effectiveness and maximize return on investment.
Marketing Mix Modeling is the future of decision making.
As the future of marketing demands more advanced statistical modeling to guide effective budget allocation, pharmaceutical companies must step up and integrate Marketing Mix Modeling (MMM) more frequently into their decision-making processes.
To support this transition, we’ve launched a dedicated content series tailored specifically for the pharmaceutical industry. Our first post explores how pharma companies can improve the effectiveness of their field force through MMM, highlighting practical strategies and data-driven insights to maximize impact.
Marketing Mix Modeling for pharmaceuticals
Let’s start with the basics. Marketing Mix Modeling (MMM) is an analytical framework used to measure both the combined and individual impact of multiple marketing channels. It takes into account not only online and offline interactions, but also market dynamics, competitive pressures, regulatory factors, and promotional events. Unlike simplified digital attribution models, MMM provides a holistic perspective on how each channel, activity, and external factor contributes to pharmaceutical sales performance. For a more detailed analysis, please see here.
There are two main types of data inputs for a Marketing Mix Model (MMM). The first is marketing or activity-related information, which includes marketing investments, offline activities, coupons, discounts, product updates, and similar initiatives. The second is market-related information, such as competitor activity, seasonality patterns, and broader market trends.
Given that field force is one of the most prominent channels in the pharmaceutical industry, MMM can provide valuable insights into its true business impact, highlight opportunities to improve efficiency, and define the limits of this channel’s effectiveness.
How field force look in an Marketing Mix Model
A typical field force activity can be treated as a channel input in a Marketing Mix Model (MMM), provided it has been properly incorporated during the data preprocessing stage. By doing so, pharmaceutical companies can accurately assess the true contribution of field force activities to overall sales performance.
Marketing Mix Modeling has the unique ability to capture both the direct and indirect effects of marketing and sales activities across channels, offering a unified view of how investments translate into outcomes. By integrating offline and online touchpoints together with external factors—such as competitive actions, regulatory changes, and promotional events—MMM enables decision-makers to measure the contribution of each channel with precision. This holistic approach goes well beyond digital attribution, helping pharmaceutical companies allocate budgets more effectively and drive sales growth with greater accuracy.
A major advantage of MMM is its capacity to distinguish between baseline sales and incremental value created by marketing activities. Baseline sales represent the demand that exists naturally due to brand strength, ongoing prescriptions, physician trust, and patient loyalty—even without new marketing investment. This clarity allows pharmaceutical companies to understand the inherent value sustained by their brand equity.
In contrast, the incremental component captures the uplift generated specifically by marketing and sales initiatives—such as field force interactions, promotional campaigns, digital engagement, or medical portal activity. By separating baseline and incremental contributions, MMM provides a clear picture of how much sales growth is driven by active investments versus the enduring value of the brand itself.
The marketing department can accurately determine the true ROI of each marketing activity.
Field force strategy for pharmaceuticals
As markets grow increasingly competitive, pharmaceutical companies must ensure they are equipped with the right tools to enhance sales effectiveness. Given that field force remains one of the most critical channels in this industry, MarSci has developed a unique approach to maximize its impact.
With our methodology, we not only uncover the true value of field force activities, but also help design strategies that enable sustainable growth.
As part of an MMM collaboration with MarSci, pharmaceutical companies receive a comprehensive set of tailored strategies to test and explore, aimed at improving the overall effectiveness of their field force.
Below, you will find a set of recommendations.
1) Rep headcount / coverage intensity
- Hypothesis: More reps per region increases incremental TRx/NBRx up to a saturation point.
- Design: Geo-split test: select matched territories; +X% reps vs control for 8–12 weeks; keep all else constant.
- MMM inputs: Weekly rep FTEs or calls/region, territory IDs, spend proxies (salary/alloc.).
- Metrics: Lift in NBRx, TRx, new patient starts, CPI-Rx, incremental ROI.
2) Territory redesign / white-space expansion
- Hypothesis: Rebalancing potential (HCP deciles, access tiers) raises incremental Rx without extra budget.
- Design: Stepped-wedge rollout: phase in redesigned maps by cohort of territories.
- MMM inputs: Territory potential scores, access tiers, launch dates of new maps.
- Metrics: Incremental TRx/NBRx vs matched control, reach (unique HCPs detailed), ROI.
3) Call frequency & cadence
- Hypothesis: Moving from 1→2 calls/quarter on decile-A HCPs yields measurable incremental Rx; diminishing returns past 3.
- Design: Multi-arm test across matched HCP lists (1, 2, 3 calls/quarter).
- MMM inputs: Weekly call counts per HCP/segment, decile labels.
- Metrics: Incremental Rx/HCP, CPI-Rx, optimal frequency curve.
4) Message framing & objection handling
- Hypothesis: Evidence-led message A (e.g., outcomes in sub-population X) outperforms message B (convenience/adherence).
- Design: A/B at HCP level with standardized leave-behinds; detail aid version logged in CRM.
- MMM inputs: Message variant ID per call, content taxonomy.
- Metrics: Detail-to-Rx conversion, script share change, qualitative rep feedback.
5) Detail length & mix
- Hypothesis: 12–15 min hybrid (F2F + remote follow-up) outperforms long single visits.
- Design: Factorial (short/long) × (F2F/remote) on matched HCPs; same frequency.
- MMM inputs: Call duration, channel mode, follow-up flags.
- Metrics: Incremental Rx/HCP, engagement rate, rep time ROI.
6) Sequencing with digital (field → email → portal)
- Hypothesis: Field-first sequence followed by compliant email and medical-portal content maximizes lift.
- Design: Sequential holdout: some HCPs get field-only; others get field+email; others field+email+portal.
- MMM inputs: Touchpoint timestamps by channel, sequence labels.
- Metrics: Incremental Rx, synergy (interaction) effects, CPI-Rx per path.
7) KOL events / small group meetings
- Hypothesis: Targeted KOL roundtables lift decile-A/B prescribing more than broad webinars.
- Design: Matched-pair geo test: KOL events vs standard detailing; constant frequency otherwise.
- MMM inputs: Event dates, HCP attendance lists, content tags.
- Metrics: Post-event Rx lift, time-to-peak, halo duration.
By combining advanced statistical modeling with a structured experimentation strategy, you can significantly improve the sales performance of existing channels. In addition, MarSci provides a unique opportunity to identify what truly works and what doesn’t, enabling you to refine your strategy and accelerate growth ahead of your competition.
Reach out today to explore our Marketing Mix Solution and discover how we can help you grow your channels more effectively.
Reach out at info@mar-sci.com
